CIK 0001628171 · Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472029180
- Phone
- 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-11 | Anders Jack Chief Financial Officer | Option exercise 10b5-1 | +10,000 | $17.00 | $170K | 120,994 |
| 2025-11-11 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −10,000 | $64.00 | $640K | 110,994 |
| 2025-11-11 | Anders Jack Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 5,418 | ||
| 2025-11-07 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +26,479 | $1.12 | $30K | 374,342 |
| 2025-11-07 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +3,521 | $4.09 | $14K | 377,863 |
| 2025-11-07 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −30,000 | $60.31 | $1.8M | 347,863 |
| 2025-11-07 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −26,479 | 0 | ||
| 2025-11-07 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,521 | 177,708 | ||
| 2025-10-17 | Cislini Jeff General Counsel | Option exercise 10b5-1 | +12,000 | $36.57 | $439K | 62,425 |
| 2025-10-17 | Cislini Jeff General Counsel | Sale 10b5-1 | −12,000 | $55.00 | $660K | 50,425 |
| 2025-10-17 | Cislini Jeff General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 18,000 | ||
| 2025-10-17 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +10,000 | $1.12 | $11K | 462,309 |
| 2025-10-17 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −10,000 | $55.00 | $550K | 452,309 |
| 2025-10-17 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 26,479 | ||
| 2025-10-16 | GOLDSMITH MARK A See Remarks | Option exercise 10b5-1 | +10,000 | $1.12 | $11K | 462,309 |
| 2025-10-16 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −10,000 | $50.47 | $505K | 452,309 |
| 2025-10-16 | GOLDSMITH MARK A See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 36,479 | ||
| 2025-10-13 | Kelsey Stephen Michael See Remarks | Option exercise 10b5-1 | +25,000 | $4.73 | $118K | 309,047 |
| 2025-10-13 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −25,000 | $48.54 | $1.2M | 284,047 |
| 2025-10-13 | Kelsey Stephen Michael See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 5,055 |
Page 15 of 18 · 352 trades